Search for:

 

Unmet Needs
- Atrial Fibrillation
- Cancer Associated Thrombosis
Science
About
Education
- Patient Advocacy
- Healthcare Professionals
Press Room
Careers

a

M

Unmet Need

Atrial Fibrillation

Cancer Associated Thrombosis

Science

The Promise of Factor XI

Abelacimab: A Novel Anticoagulant

Clinical Development Program

About

Milestones & Achievements

Education

Patient Advocacy

Healthcare Professionals

Press Room

Careers

Search for:

Publication and Congress - April 11, 2024

Targeting factor XI and factor XIa to prevent thrombosis

Blood

Contact Us
If you would like to get in touch with Anthos Therapeutics, please use the details provided, and we will get back to you soon.





Anthos Therapeutics
99 High Street
Boston, MA 02110

+1 617.430.6940

info@anthostherapeutics.com 
investors@anthostherapeutics.com
LILACTIMI76@anthostherapeutics.com





© 2024 Anthos Therapeutics. All rights reserved.